According to recent research from the University of East Anglia, combined hormone replacement therapy (HRT) reduces women’s risk of early death from all causes.
This in-depth study followed-up on thousands of women in the UK, comparing the risk of death of those taking hormone therapy with those not using it, over many years. That research found that the risk of death from all causes remains neutral for healthy women taking estrogen-only therapy. But for healthy women taking combined estrogen and progestogen HRT, the overall risk of death from all causes is reduced by almost ten percent.
In this article the hormone replacement therapy experts at SottoPelle® explain the results of this study and discuss how HRT may be able to help women live longer, healthier lives.
Study on Hormone Therapy and Women’s Risk of Early Death
This study used the data from primary care providers in the UK. The researchers followed the medical records of 105,199 women in good health who were between 46 and 65 years old who were given hormone therapy, with an average follow-up of 13 years. These women’s health was compared with 224,643 women of the same age, who were non-HRT users.
Unlike previous studies which only adjusted for demographic and/or lifestyle factors, this study also adjusted for medical conditions including type 2 diabetes, high blood pressure, heart and artery disease, hysterectomy, ovary removal, body mass index, and smoking.
The data in this study, which was commissioned by the Institute and Faculty of Actuaries (IFoA), was the first to analyze the impact of HRT on women’s overall life expectancy using primary care data.
Of the more than 300,000 women in the study a total of 21,751 women in the study died over the average 13.5 years follow-up per participant. 15,422 non-users of hormone therapy died. However, only 6,329 HRT users died in the average 13.5 year follow-up.
When adjusted for a variety of factors, the researchers concluded that “combined HRT [estrogen + progesten] was associated with a 9% lower risk of all-cause mortality and estrogen-only formulation was not associated with any significant changes.”
Implications of Hormone Therapy and Women’s Risk of Early Death
Sadly, many women are still reluctant to undergo hormone therapy for the treatment of menopause, because of the controversial results of some outdated and erroneous studies from over two decades ago. As Professor Elena Kulinskaya from the University of East Anglia in Norwich, England said: “Despite the effectiveness of HRT in relieving menopausal symptoms … untreated menopausal symptoms eventually increase the risks of other health conditions, such as osteoporosis and cardiovascular disease, and incur additional costs to the healthcare systems.
Louise Pryor, IFoA President, summed up the research by saying: “This study supports the emerging consensus that, for most women, the benefits of HRT outweighs the harm. We hope this research will help … support women deciding whether to start or continue with HRT.”
SottoPelle® Method Hormone Therapy for Women
SottoPelle® Method 100% natural bioidentical hormone replacement therapy method can help restore a woman’s body and mind to optimal balance during perimenopause and menopause, in addition to protecting a woman’s body from a wide variety of diseases including type 2 diabetes, heart disease and osteoporosis.
And hormone replacement therapy pellets offer several advantages, including NO daily pills, NO painful weekly shots, and NO messy creams. Additionally, SottoPelle® pellet therapy utilizes bioidentical hormones that are safer, more effective, and more natural than lab-created synthetics. Because bioidentical hormones are identical to the body’s own hormones, they offer more effective results, with fewer side-effects and risks.
Research has clearly shown that estrogen-only hormone therapy is not linked to an increased risk of death from any cause – and that combined HRT use is linked to an overall lower risk of death in women after menopause.
If you are a woman who is experiencing the symptoms of perimenopause or menopause, talk to us about SottoPelle® Method hormone therapy today.
Call 201-225-2525 or schedule a consultation at: https://advancedhormonesolutions.com/consultation-form/
Article created by SottoPelle and used by permission of SottoPelle. Advanced Hormone Solutions is a “Certified” SottoPelle provider